首站-论文投稿智能助手
典型文献
The comparison of survival between active surveillance or watchful waiting and focal laser ablation in patients with low-risk prostate cancer
文献摘要:
Prostate cancer(PCa)is the second-most common cancer among men.Both active surveillance or watchful waiting(AS/WW)and focal laser ablation(FLA)can avoid the complications caused by radical treatment.How to make the choice between these options in clinical practice needs further study.Therefore,this study aims to compare and analyze their effects based on overall survival(OS)and cancer-specific survival(CSS)to obtain better long-term benefits.We included patients with low-risk PCa from the Surveillance Epidemiology and End Results database of 2010-2016.Multivariate Cox proportional hazard analyses were conducted for OS and CSS in the two groups.To eliminate bias,this study applied a series of sensitivity analyses.Moreover,Kaplan-Meier curves were plotted to obtain survival status.A total of 18 841 patients with low-risk PCa were included,with a median of 36-month follow-up.According to the multivariate Cox proportional hazard regression,the FLA group presented inferior survival benefits in OS than the AS/WW group(hazard ratio[HR]:2.13,95%confidence interval[Cl]:1.37-3.33,P<0.05).After adjusting for confounders,the result persisted(HR:1.69,95%Cl:1.02-2.81,P<0.05).According to the results of the sensitivity analysis,the inverse probability of the treatment weighing model indicated the same result in OS.In conclusion,AS/WW and FLA have the advantage of fewer side effects and the benefit of avoiding overtreatment compared with standard treatment.Our study suggested that AS/WW provides more survival benefits for patients with low-risk PCa.More relevant researches and data will be needed for further clarity.
文献关键词:
作者姓名:
Jia-Kun Li;Chi-Chen Zhang;Shi Qiu;Kun Jin;Bo-Yu Cai;Qi-Ming Yuan;Xing-Yu Xiong;Lian-Sha Tang;Di Jin;Xiang-Hong Zhou;Yi-Ge Bao;Lu Yang;Qiang Wei
作者机构:
Department of Urology,Institute of Urology,West China Hospital of Sichuan University,Chengdu 610041,China;Department of Biotherapy,Cancer Center,West China Hospital of Sichuan University,Chengdu 610041,China
引用格式:
[1]Jia-Kun Li;Chi-Chen Zhang;Shi Qiu;Kun Jin;Bo-Yu Cai;Qi-Ming Yuan;Xing-Yu Xiong;Lian-Sha Tang;Di Jin;Xiang-Hong Zhou;Yi-Ge Bao;Lu Yang;Qiang Wei-.The comparison of survival between active surveillance or watchful waiting and focal laser ablation in patients with low-risk prostate cancer)[J].亚洲男性学杂志(英文版),2022(05):494-499
A类:
watchful,overtreatment
B类:
comparison,survival,between,active,surveillance,waiting,focal,laser,ablation,patients,risk,prostate,cancer,Prostate,PCa,second,most,common,among,Both,AS,WW,FLA,complications,caused,by,radical,How,make,choice,these,options,clinical,practice,needs,further,study,Therefore,this,aims,analyze,their,effects,overall,OS,specific,CSS,obtain,better,long,term,benefits,We,included,from,Surveillance,Epidemiology,End,Results,database,Multivariate,Cox,proportional,hazard,analyses,were,conducted,two,groups,To,eliminate,bias,applied,series,sensitivity,Moreover,Kaplan,Meier,curves,plotted,status,total,median,month,follow,According,multivariate,regression,presented,inferior,than,ratio,confidence,interval,Cl,After,adjusting,confounders,persisted,results,analysis,inverse,probability,weighing,model,indicated,same,In,conclusion,have,advantage,fewer,side,avoiding,compared,standard,Our,suggested,that,provides,more,relevant,researches,will,needed,clarity
AB值:
0.533551
相似文献
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang;Wei Wan;Shuai Zhang;Jingwen Wang;Ru Feng;Jiangtao Li;Junyue Chai;Hebing Zhou;Liru Wang;Yuping Zhong;Xiaodong Mo;Mengzhu Shen;Hongmei Jing;Hui Liu-Department of Hematology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Hematology,Peking University Third Hospital,Beijing 100191,China;Department of Hematology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Hematology,Beijing No.6 Hospital,Beijing 100007,China;Department of Hematology,Beijing Luhe Hospital,Capital Medical University,Beijing 101100,China;Department of Hematology,Fuxing Hospital,Capital Medical University,Beijing 100038,China;Department of Hematology,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100043,China;Peking University People's Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100044,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
CT-based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma:A multicenter study
Jing-Wei Wei;Si-Rui Fu;Jie Zhang;Dong-Sheng Gu;Xiao-Qun Li;Xu-Dong Chen;Shuai-Tong Zhang;Xiao-Fei He;Jian-Feng Yan;Li-Gong Lu;Jie Tian-Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China;Beijing Key Laboratory of Molecular Imaging,Beijing 100190,China;University of Chinese Academy of Sciences,Beijing 100049,China;Zhuhai Interventional Medical Center,Zhuhai Precision Medical Center,Zhuhai People's Hospital,Zhuhai Hospital of Jinan University,Zhuhai 519000,China;Department of Radiology,Zhuhai Precision Medical Center,Zhuhai People's Hospital,Zhuhai Hospital of Jinan University,Zhuhai 519000,China;Department of Interventional Treatment,Zhongshan City People's Hospital,Zhongshan 528400,China;Department of Radiology,Shenzhen People's Hospital,Shenzhen 518000,China;Interventional Diagnosis and Treatment Department,Nanfang Hospital,Southern Medical University,Guangzhou,510000,China;Department of Radiology,Yangjiang People's Hospital,Yangjiang 529500,China;Beijing Advanced Innovation Center for Big Data-Based Precision Medicine,School of Medicine and Engineering,Beihang University,Beijing 100191,China;Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education,School of Life Science and Technology,Xidian University,Xi'an 710126,China
Prognostic nomogram incorporating radiological features for predicting overall survival in patients with AIDS-related non-Hodgkin lymphoma
Li Xueqin;Pan Ziang;Wang Xing;Hu Tianli;Ye Wen;Jiang Dongmei;Shen Wen;Liu Jinxin;Shi Yuxin;Xia Shuang;Li Hongjun-Radiological Department, Beijing You'an Hospital Affiliated of Capital Medical University, Beijing 100069, China;Neurological Department, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;Radiological Department, The Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong 510060, China;Radiological Department, Shanghai Public Health Clinical Center, Affiliated of Fudan University, Shanghai 201058, China;Radiation Department, Tianjin First Central Hospital, Tianjin 300170, China;Radiological Department, Tianjin First Central Hospital, Tianjin 300192, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Coupling radiomics analysis of CT image with diversification of tumor ecosystem:A new insight to overall survival in stage Ⅰ-Ⅲ colorectal cancer
Yanqi Huang;Lan He;Zhenhui Li;Xin Chen;Chu Han;Ke Zhao;Yuan Zhang;Jinrong Qu;Yun Mao;Changhong Liang;Zaiyi Liu-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Radiology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center,Kunming 650118,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Department of Radiology,the Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450003,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer
Dan Lyu;Binliang Liu;Bo Lan;Xiaoying Sun;Lixi Li;Jingtong Zhai;Haili Qian;Fei Ma-Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Breast Cancer Medical Oncology,Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha 410013,China;Department of Medical Oncology,Cancer Hospital of Huanxing Chaoyang District,Beijing 100122,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。